{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-238857","form_type":"8-K","ticker":"AMRX","cik":"0001723128","company_name":"Amneal Pharmaceuticals, Inc.","filed_at":"2022-09-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.814306+00:00","generated_at":"2026-06-23T15:33:15.615322+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Amneal appoints Gustavo Pesquin as EVP, Chief Commercial Officer – Specialty","bullets":["Pesquin joins from Sanofi, where he was North America Head for General Medicines.","Base salary $525,000; target annual bonus 60% of base salary; RSU grant of $1,000,000 vesting over 4 years.","Severance: 150% of base salary plus pro-rata bonus and 18 months benefits if terminated without cause or for good reason.","Effective September 6, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-238857","json":"https://secwatch.observer/filing/0001193125-22-238857.json","markdown":"https://secwatch.observer/filing/0001193125-22-238857.md","text":"https://secwatch.observer/filing/0001193125-22-238857.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1723128/000119312522238857/0001193125-22-238857-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1723128/000119312522238857/d385461d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T15:33:15.615322+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2290c92d27","claim":"Gustavo J. Pesquin was appointed as Executive Vice President and Chief Commercial Officer – Specialty at Amneal Pharmaceuticals, Inc..","evidence_excerpt":"On September 1, 2022, the Board of Directors (the “ Board ”) of Amneal Pharmaceuticals, Inc. (the “ Company ”) appointed Gustavo J. Pesquin as the Company’s Executive Vice President and Chief Commercial Officer – Specialty, effective September 6, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1723128/000119312522238857/0001193125-22-238857-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President and Chief Commercial Officer – Specialty"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}